文献速递临床试验与 GCP真实世界研究与卫生经济

改善严重精神疾病患者心血管健康与生活质量:随机对照试验研究方案

Improving cardiovascular health and quality of life in people with severe mental illness: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2018-07-11

该随机对照试验针对澳大利亚约30万严重精神疾病(SMI)成人,评估基于Flinders慢性病管理程序(CCM)的干预能否降低心血管疾病(CVD)风险并改善生活质量(QoL)。研究同时识别患者、临床和组织层面的实施要素,首要目标为将CVD风险降低20%。

要点

  • SMI患者CVD风险因素高发且推荐监测与风险降低服务落实不足。
  • 干预整合Flinders CCM程序,以患者为中心构建自我管理能力。
  • 主要结局为CVD风险与生活质量,并评估健康经济学。

核心结论

  • 该研究为全球首个在SMI人群中应用Flinders程序的大规模试验,首要目标是将CVD风险降低20%并改善生活质量。

研究设计与样本

  • 随机对照试验,参与者从社区公共精神卫生服务机构招募。
  • 干预通过Flinders慢性病管理程序整合推荐的身体健康照护。

关键数值与推荐

  • 主要结局指标为CVD风险与生活质量。
  • 首要目标为将CVD风险降低20%。

临床怎么用

  • Flinders程序可由任何临床学科及受督导同伴在多样场景中实施,便于全国及海外推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The estimated 300,000 adults in Australia with severe mental illness (SMI) have markedly reduced life expectancy compared to the general population, mainly due to physical health comorbidities. Cardiovascular disease (CVD) is the commonest cause of early death and people with SMI have high rates of most modifiable risk factors, with associated quality of life (QoL) reduction. High blood pressure, smoking, dyslipidaemia, diabetes and obesity are major modifiable CVD risk factors. Poor delivery of recommended monitoring and risk reduction is a national and international problem. Therefore, effective preventive interventions to safeguard and support physical health are urgently needed in this population. METHODS: This trial used a rigorous process, including extensive piloting, to develop an intervention that delivers recommended physical health care to reduce CVD risk and improve QoL for people with SMI. Components of this intervention are integrated using the Flinders Program of chronic condition management (CCM) which is a comprehensive psychosocial care planning approach that places the patient at the centre of their care, and focuses on building their self-management capacity within a collaborative approach, therefore providing a recovery-oriented framework. The primary project aim is to evaluate the effectiveness and health economics of the CCM intervention. The main outcome measures examine CVD risk and quality of life. The second aim is to identify essential components, enablers and barriers at patient, clinical and organisational levels for national, sustained implementation of recommended physical health care delivery to people with SMI. Participants will be recruited from a community-based public psychiatric service. DISCUSSION: This study constitutes the first large-scale trial, worldwide, using the Flinders Program with this population. By combining a standardised yet flexible motivational process with a targeted set of evidence-based interventions, the chief aim is to reduce CVD risk by 20%. If achieved, this will be a ground-breaking outcome, and the program will be subsequently translated nationwide and abroad. The trial will be of great interest to people with mental illness, family carers, mental health services, governments and primary care providers because the Flinders Program can be delivered in diverse settings by any clinical discipline and supervised peers. TRIAL REGISTRATION: Australian and New Zealand Clinical Trials Registry, ACTRN12617000474358 . Registered on 31 March 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Battersby M, Kidd MR, Licinio J, et al. Improving cardiovascular health and quality of life in people with severe mental illness: study protocol for a randomised controlled trial. Trials. 2018. PMID: 29996886. doi:10.1186/s13063-018-2748-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。